| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ESSA Pharma Inc. | President and CEO, Director | Common Shares | 0 | $0 | $0.2400 | 09 Oct 2025 | Direct |
| CTI BIOPHARMA CORP | Director | Stock Option (Right to Buy) | 0 | 26 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EPIX | ESSA Pharma Inc. | 09 Oct 2025 | 1 | $0 | 4 | President and CEO, Director | 15 Oct 2025, 12:04 |
| EPIX | ESSA Pharma Inc. | 25 Mar 2024 | 1 | $0 | 4 | Chief Executive Officer, Director | 28 Mar 2024, 12:27 |
| EPIX | ESSA Pharma Inc. | 14 Dec 2023 | 1 | +$21,213 | 4 | Chief Executive Officer, Director | 18 Dec 2023, 21:57 |
| /report/000089924323016481-parkinson-david-ross-2023-06-26 | CTI BIOPHARMA CORP | 26 Jun 2023 | 7 | $0 | 4 | Director | 26 Jun 2023, 16:05 |
| /report/000089924323010985-parkinson-david-ross-2023-04-05 | CTI BIOPHARMA CORP | 05 Apr 2023 | 1 | $0 | 4 | Director | 07 Apr 2023, 18:25 |
| EPIX | ESSA Pharma Inc. | 22 Dec 2022 | 2 | +$59,041 | 4 | Chief Executive Officer, Director | 05 Jan 2023, 17:18 |
| EPIX | ESSA Pharma Inc. | 30 Jun 2022 | 1 | +$14,456 | 4 | Chief Executive Officer, Director | 05 Jul 2022, 13:39 |
| EPIX | ESSA Pharma Inc. | 29 Jun 2022 | 1 | $0 | 4 | Chief Executive Officer, Director | 01 Nov 2022, 11:06 |
| /report/000089924322010778-parkinson-david-ross-2022-03-09 | CTI BIOPHARMA CORP | 09 Mar 2022 | 1 | $0 | 4 | Director | 11 Mar 2022, 18:45 |